rs201590889
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001130144.3(LTBP3):c.804C>T(p.Pro268Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,573,436 control chromosomes in the GnomAD database, including 282 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 15 hom., cov: 31)
Exomes 𝑓: 0.017 ( 267 hom. )
Consequence
LTBP3
NM_001130144.3 synonymous
NM_001130144.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.49
Publications
1 publications found
Genes affected
LTBP3 (HGNC:6716): (latent transforming growth factor beta binding protein 3) The protein encoded by this gene forms a complex with transforming growth factor beta (TGF-beta) proteins and may be involved in their subcellular localization. Activation of this complex requires removal of the encoded binding protein. This protein also may play a structural role in the extracellular matrix. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
LTBP3 Gene-Disease associations (from GenCC):
- brachyolmia-amelogenesis imperfecta syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- geleophysic dysplasia 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Acromicric dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- geleophysic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-65553761-G-A is Benign according to our data. Variant chr11-65553761-G-A is described in ClinVar as Benign. ClinVar VariationId is 464026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.49 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0119 (1805/151936) while in subpopulation NFE AF = 0.0183 (1243/67906). AF 95% confidence interval is 0.0175. There are 15 homozygotes in GnomAd4. There are 845 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LTBP3 | NM_001130144.3 | c.804C>T | p.Pro268Pro | synonymous_variant | Exon 3 of 28 | ENST00000301873.11 | NP_001123616.1 | |
| LTBP3 | NM_021070.4 | c.804C>T | p.Pro268Pro | synonymous_variant | Exon 3 of 27 | NP_066548.2 | ||
| LTBP3 | NM_001164266.1 | c.453C>T | p.Pro151Pro | synonymous_variant | Exon 3 of 27 | NP_001157738.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0119 AC: 1805AN: 151818Hom.: 15 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1805
AN:
151818
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0127 AC: 2296AN: 180764 AF XY: 0.0128 show subpopulations
GnomAD2 exomes
AF:
AC:
2296
AN:
180764
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0169 AC: 24016AN: 1421500Hom.: 267 Cov.: 34 AF XY: 0.0164 AC XY: 11580AN XY: 704924 show subpopulations
GnomAD4 exome
AF:
AC:
24016
AN:
1421500
Hom.:
Cov.:
34
AF XY:
AC XY:
11580
AN XY:
704924
show subpopulations
African (AFR)
AF:
AC:
87
AN:
33074
American (AMR)
AF:
AC:
115
AN:
40820
Ashkenazi Jewish (ASJ)
AF:
AC:
143
AN:
25630
East Asian (EAS)
AF:
AC:
8
AN:
38570
South Asian (SAS)
AF:
AC:
155
AN:
82662
European-Finnish (FIN)
AF:
AC:
1295
AN:
36144
Middle Eastern (MID)
AF:
AC:
5
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
21519
AN:
1099632
Other (OTH)
AF:
AC:
689
AN:
59256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1557
3113
4670
6226
7783
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0119 AC: 1805AN: 151936Hom.: 15 Cov.: 31 AF XY: 0.0114 AC XY: 845AN XY: 74240 show subpopulations
GnomAD4 genome
AF:
AC:
1805
AN:
151936
Hom.:
Cov.:
31
AF XY:
AC XY:
845
AN XY:
74240
show subpopulations
African (AFR)
AF:
AC:
151
AN:
41450
American (AMR)
AF:
AC:
49
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
20
AN:
3466
East Asian (EAS)
AF:
AC:
1
AN:
5136
South Asian (SAS)
AF:
AC:
8
AN:
4782
European-Finnish (FIN)
AF:
AC:
316
AN:
10602
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1243
AN:
67906
Other (OTH)
AF:
AC:
17
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Brachyolmia-amelogenesis imperfecta syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.